CDC/Health Resources and Services Administration (HRSA) Advisory Committee on HIV and STD Prevention and Treatment, 62996 [E8-25129]

Download as PDF 62996 Federal Register / Vol. 73, No. 205 / Wednesday, October 22, 2008 / Notices announces the following meeting of the aforementioned committee: Time and Date: 8:30 a.m.–5 p.m., November 20, 2008. Place: CDC, Global Communications Center, Building 19, Rooms 245–246, 1600 Clifton Road, Atlanta, Georgia 30333. Status: Open to the public, limited only by the space available. Purpose: The committee shall advise the Secretary, HHS, and the Director, CDC, concerning strategies and goals for the programs and research within the national centers; shall conduct peer-review of scientific programs; and monitor the overall strategic direction and focus of the national centers. The board, after conducting its periodic reviews, shall submit a written description of the results of the review and its recommendations to the Director, CDC. The board shall perform second-level peer review of applications for grants-in-aid for research and research training activities, cooperative agreements, and research contract proposals relating to the broad areas within the national centers. Matters to be Discussed: The agenda will include detailed discussions on the following issues: BioSense Strategic Planning, Open Source Models, and Organizational Issues for NCPHI. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Scott J.N. McNabb, Ph.D., M.S., Designated Federal Officer, NCPHI, CDC, 1600 Clifton Road, NE., Mailstop E78, Atlanta, Georgia, 30333, Telephone: (404) 409–3898. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the CDC and the Agency for Toxic Substances and Disease Registry. Dated: October 15, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–25131 Filed 10–21–08; 8:45 am] Place: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, Bethesda, Maryland 20852, Telephone: (301) 822–9200, Fax: (301) 822–9201. Status: Open to the public, limited only by the space available. The meeting room will accommodate approximately 100 people. Purpose: This Committee is charged with advising the Director, CDC and the Administrator, HRSA, regarding activities related to prevention and control of HIV/ AIDS and other STDs, the support of health care services to persons living with HIV/ AIDS, and education of health professionals and the public about HIV/AIDS and other STDs. Matters to be Discussed: Agenda items include issues pertaining to (1) HRSA Bureau of Primary Health Care focusing on Community Health Centers; (2) CDC’s revised HIV incidence and prevalence estimates; (3) Key expert clinical data—Domestic and the President’s Emergency Plan for AIDS Relief; and (4) Presentation on interface between mental health services and HIV/STD issues, including risk issues and comprehensive and synergistic care. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Traci Sears, Committee Management Specialist, CDC, Strategic Business Unit, 1600 Clifton Road, NE., Mailstop E–77, Atlanta, Georgia 30333, Telephone: (404) 498–2732, Fax: (404) 498–2708. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for both the CDC and the Agency for Toxic Substances and Disease Registry. Dated: October 15, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–25129 Filed 10–21–08; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4163–18–P Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 50 people. To accommodate public participation in the meeting, a conference telephone line will be available. The public is welcome to participate during the public comment periods by calling (866) 919–3560 and entering code 4168828. The public comment periods are tentatively scheduled for 4:30 p.m.–4:45 p.m. on November 13 and from 2:30 p.m.–2:45 p.m. on November 14, 2008. Purpose: The Ethics Subcommittee will provide guidance to the ACD, CDC, regarding a broad range of public health ethics questions and issues arising from programs, scientists and practitioners. Matters To Be Discussed: Agenda items will include the following topics: CDC’s Healthiest Nation Initiative, priorities of the Advisory Committee to the Director, ethical guidance for ventilator distribution, ethical guidance for use of traveler restrictions, ethical guidance for public health emergency preparedness and response, survey of CDC staff about principles of ethical public health practice, development of a web-based course on public health ethics, and the CDC– Tuskegee University Public Health Ethics Fellowship. For Further Information Contact: For security reasons, members of the public interested in attending the meeting should contact Drue Barrett, PhD, Designated Federal Officer, Ethics Subcommittee, CDC, 1600 Clifton Road, NE., M/S D–50, Atlanta, Georgia 30333. Telephone (404) 639–4690. Email: dbarrett@cdc.gov. The deadline for notification of attendance is November 7, 2008. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: October 15, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–25126 Filed 10–21–08; 8:45 am] Centers for Disease Control and Prevention Ethics Subcommittee, Advisory Committee to the Director, Centers for Disease Control and Prevention (CDC) DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention (CDC) sroberts on PROD1PC70 with NOTICES CDC/Health Resources and Services Administration (HRSA) Advisory Committee on HIV and STD Prevention and Treatment In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the CDC announces the following meeting of the aforementioned committee: Times and Dates: 8 a.m.–5 p.m., November 17, 2008. 8 a.m.–3 p.m., November 18, 2008. VerDate Aug<31>2005 17:50 Oct 21, 2008 Jkt 217001 BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention announces the aforementioned subcommittee meeting. Name: Ethics Subcommittee, Advisory Committee to the Director (ACD), CDC. Times and Dates: 1 p.m.–5 p.m., November 13, 2008. 8 a.m.–3 p.m., November 14, 2008. Place: Centers for Disease Control and Prevention, Thomas R. Harkin Global Communication Center, 1600 Clifton Road, Atlanta, Georgia 30333. PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 Centers for Disease Control and Prevention Interagency Committee on Smoking and Health (ICSH) In accordance with section 10(a) (2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following Meeting of the aforementioned committee: Time and Date: 9 a.m.–4:30 p.m., December 8, 2008. E:\FR\FM\22OCN1.SGM 22OCN1

Agencies

[Federal Register Volume 73, Number 205 (Wednesday, October 22, 2008)]
[Notices]
[Page 62996]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-25129]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention (CDC)


CDC/Health Resources and Services Administration (HRSA) Advisory 
Committee on HIV and STD Prevention and Treatment

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the CDC announces the following meeting 
of the aforementioned committee:

    Times and Dates: 8 a.m.-5 p.m., November 17, 2008. 8 a.m.-3 
p.m., November 18, 2008.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, Maryland 20852, Telephone: (301) 822-9200, 
Fax: (301) 822-9201.
    Status: Open to the public, limited only by the space available. 
The meeting room will accommodate approximately 100 people.
    Purpose: This Committee is charged with advising the Director, 
CDC and the Administrator, HRSA, regarding activities related to 
prevention and control of HIV/AIDS and other STDs, the support of 
health care services to persons living with HIV/AIDS, and education 
of health professionals and the public about HIV/AIDS and other 
STDs.
    Matters to be Discussed: Agenda items include issues pertaining 
to (1) HRSA Bureau of Primary Health Care focusing on Community 
Health Centers; (2) CDC's revised HIV incidence and prevalence 
estimates; (3) Key expert clinical data--Domestic and the 
President's Emergency Plan for AIDS Relief; and (4) Presentation on 
interface between mental health services and HIV/STD issues, 
including risk issues and comprehensive and synergistic care. Agenda 
items are subject to change as priorities dictate.
    Contact Person for More Information: Traci Sears, Committee 
Management Specialist, CDC, Strategic Business Unit, 1600 Clifton 
Road, NE., Mailstop E-77, Atlanta, Georgia 30333, Telephone: (404) 
498-2732, Fax: (404) 498-2708.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining 
to announcements of meetings and other committee management 
activities, for both the CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: October 15, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.

[FR Doc. E8-25129 Filed 10-21-08; 8:45 am]
BILLING CODE 4163-18-P